Framingham cardiovascular disease risk scores and incident frailty: the English longitudinal study of ageing

Catharine R Gale, Cyrus Cooper, Avan Aihie Sayer, Catharine R Gale, Cyrus Cooper, Avan Aihie Sayer

Abstract

Cross-sectional studies show that frailty is common in older people with cardiovascular disease. Whether older people at higher risk of developing cardiovascular disease are more likely to become frail is unclear. We used multinomial logistic regression to examine the prospective relation between Framingham cardiovascular disease risk scores and incidence of physical frailty or pre-frailty, defined according to the Fried criteria, in 1,726 men and women aged 60 to over 90 years from the English Longitudinal Study of Ageing who had no history of cardiovascular disease at baseline. Men and women with higher Framingham cardiovascular risk scores were more likely to become frail over the 4-year follow-up period. For a standard deviation higher score at baseline, the relative risk ratio (95 % confidence interval) for incident frailty, adjusted for sex and baseline frailty status, was 2.76 (2.18, 3.49). There was a significant association between Framingham cardiovascular risk score and risk of pre-frailty: 1.69 (1.46, 1.95). After further adjustment for other potential confounding factors, the relative risk ratios for frailty and pre-frailty were 2.15 (1.68, 2.75) and 1.50 (1.29, 1.74), respectively. The associations were unchanged after excluding incident cases of cardiovascular disease. Separate adjustment for each component of the risk score suggested that no single component was driving the associations between cardiovascular risk score and incident pre-frailty or frailty. Framingham cardiovascular risk scores may be useful for predicting the development of physical frailty in older people. We now need to understand the biological mechanisms whereby cardiovascular risk increases the risk of frailty.

References

    1. Afilalo J, Karunananthan S, Eisenberg MJ, Alexander KP, Bergman H. Role of frailty in patients with cardiovascular disease. Am J Cardiol. 2009;103:1616–1621. doi: 10.1016/j.amjcard.2009.01.375.
    1. Afilalo J, Alexander KP, Mack MJ, Maurer MS, Green P, Allen LA, Popma JJ, Ferrucci L, Forman DE. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol. 2014;63:747–762. doi: 10.1016/j.jacc.2013.09.070.
    1. Bandeen-Roche K, Xue QL, Ferrucci L, Walston J, Guralnik JM, Chaves P, Zeger SL, Fried LP. Phenotype of frailty: characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci. 2006;61:262–266. doi: 10.1093/gerona/61.3.262.
    1. Banks J, Karlsen S, Oldfield Z. Socio-economic position. In: Marmot M, Banks J, Blundell R, Lessof C, Nazroo J, editors. Health, wealth and lifestyles of the older population in England. London: Institute of Fiscal Studies; 2003. pp. 71–125.
    1. Baylis D, Bartlett DB, Syddall HE, Ntani G, Gale CR, Cooper C, Lord JM, Sayer AA. Immune-endocrine biomarkers as predictors of frailty and mortality: a 10-year longitudinal study in community-dwelling older people. Age (Dordr) 2012
    1. Bergman H, Ferrucci L, Guralnik J, Hogan DB, Hummel S, Karunananthan S, Wolfson C. Frailty: an emerging research and clinical paradigm–issues and controversies. J Gerontol A Biol Sci Med Sci. 2007;62:731–737. doi: 10.1093/gerona/62.7.731.
    1. Bouillon K, Batty GD, Hamer M, Sabia S, Shipley MJ, Britton A, Singh-Manoux A, Kivimaki M. Cardiovascular disease risk scores in identifying future frailty: the Whitehall II prospective cohort study. Heart. 2013;99:737–742. doi: 10.1136/heartjnl-2012-302922.
    1. Brayne C, Nickson J, McCracken C, Gill C, Johnson AL. Cognitive function and dementia in six areas of England and Wales: the distribution of MMSE and prevalence of GMS organicity level in the MRC CFA study. Psychol Med. 1998;28:319–335. doi: 10.1017/S0033291797006272.
    1. Buchman AS, Yu L, Wilson RS, Schneider JA, Bennett DA. Association of brain pathology with the progression of frailty in older adults. Neurology. 2013;80:2055–2061. doi: 10.1212/WNL.0b013e318294b462.
    1. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381:752–762. doi: 10.1016/S0140-6736(12)62167-9.
    1. D’Agostino RB, Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117:743–753. doi: 10.1161/CIRCULATIONAHA.107.699579.
    1. Elbaz A, Ripert M, Tavernier B, Fevrier B, Zureik M, Gariepy J, Alperovitch A, Tzourio C. Common carotid artery intima-media thickness, carotid plaques, and walking speed. Stroke. 2005;36:2198–2202. doi: 10.1161/01.STR.0000181752.16915.5c.
    1. Elbaz A, Shipley MJ, Nabi H, Brunner EJ, Kivimaki M, Singh-Manoux A. Trajectories of the Framingham general cardiovascular risk profile in midlife and poor motor function later in life: the Whitehall II study. Int J Cardiol. 2014;172:96–102. doi: 10.1016/j.ijcard.2013.12.051.
    1. Espinoza SE, Jung I, Hazuda H. Frailty transitions in the San Antonio Longitudinal Study of Aging. J Am Geriatr Soc. 2012;60:652–660. doi: 10.1111/j.1532-5415.2011.03882.x.
    1. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–M156. doi: 10.1093/gerona/56.3.M146.
    1. Gale CR, Baylis D, Cooper C, Sayer AA. Inflammatory markers and incident frailty in men and women: the English Longitudinal Study of Ageing. Age. 2013;35:2493–2501. doi: 10.1007/s11357-013-9528-9.
    1. Gale CR, Cooper C, Aihie Sayer A (2014a) Prevalence of frailty and disability: findings from the English Longitudinal Study of Ageing. Age Ageing, in press
    1. Gale CR, Cooper C, Deary IJ, Aihie Sayer A. Psychological well-being and incident frailty in men and women: the English Longitudinal Study of Ageing. Psychol Med. 2014;44:697–706. doi: 10.1017/S0033291713001384.
    1. Gill TM, Gahbauer EA, Allore HG, Han L. Transitions between frailty states among community-living older persons. Arch Intern Med. 2006;166:418–423. doi: 10.1001/archinte.166.4.418.
    1. Kaffashian S, Dugravot A, Elbaz A, Shipley MJ, Sabia S, Kivimaki M, Singh-Manoux A. Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores. Neurology. 2013;80:1300–1306. doi: 10.1212/WNL.0b013e31828ab370.
    1. Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014
    1. Lee JS, Auyeung TW, Leung J, Kwok T, Woo J. Transitions in frailty states among community-living older adults and their associated factors. J Am Med Dir Assoc. 2014;15:281–286. doi: 10.1016/j.jamda.2013.12.002.
    1. Marmot M, Oldfield Z, Clemens S, Blake M, Phelps A, Nazroo J, Steptoe A, Rogers N, Bank J (2013) English Longitudinal Study of Ageing: waves 0-5, 1998-2011 [computer file], 20th edn. SN: 5050. UK Data Archive [distributor], Colchester
    1. Morley JE, Perry HM, 3rd, Miller DK. Editorial: something about frailty. J Gerontol A Biol Sci Med Sci. 2002;57:M698–M704. doi: 10.1093/gerona/57.11.M698.
    1. Newman AB, Gottdiener JS, McBurnie MA, Hirsch CH, Kop WJ, Tracy R, Walston JD, Fried LP, Cardiovascular Health Study Research G Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci. 2001;56:M158–M166. doi: 10.1093/gerona/56.3.M158.
    1. Noh TS, Moon SH, Cho YS, Hong SP, Lee EJ, Choi JY, Kim BT, Lee KH. Relation of carotid artery 18 F-FDG uptake to C-reactive protein and Framingham risk score in a large cohort of asymptomatic adults. J Nucl Med: Off Publ, Soc Nucl Med. 2013;54:2070–2076. doi: 10.2967/jnumed.113.119602.
    1. Ofstedal M, Fisher G, Hertzog R (2005) Documentation of cognitive functioning measures in the Health and Retirement Study. . Accessed February 2014
    1. Park CS, Ihm SH, Yoo KD, Kim DB, Lee JM, Kim HY, Chung WS, Seung KB, Kim JH. Relation between C-reactive protein, homocysteine levels, fibrinogen, and lipoprotein levels and leukocyte and platelet counts, and 10-year risk for cardiovascular disease among healthy adults in the USA. Am J Cardiol. 2010;105:1284–1288. doi: 10.1016/j.amjcard.2009.12.045.
    1. Puts MT, Visser M, Twisk JW, Deeg DJ, Lips P. Endocrine and inflammatory markers as predictors of frailty. Clin Endocrinol (Oxf) 2005;63:403–411. doi: 10.1111/j.1365-2265.2005.02355.x.
    1. Rockwood K, Fox RA, Stolee P, Robertson D, Beattie BL. Frailty in elderly people: an evolving concept. Can Med Assoc J. 1994;150:489–495.
    1. Roth M, Huppert FA, Mountjoy CQ, Tym E. The revised Cambridge examination for mental disorders of the elderly. Cambridge: Cambridge University Press; 1999.
    1. Savela SL, Koistinen P, Stenholm S, Tilvis RS, Strandberg AY, Pitkala KH, Salomaa VV, Strandberg TE. Leisure-time physical activity in midlife is related to old age frailty. J Gerontol A Biol Sci Med Sci. 2013;68:1433–1438. doi: 10.1093/gerona/glt029.
    1. Sayer AA, Dennison EM, Syddall HE, Gilbody HJ, Phillips DI, Cooper C. Type 2 diabetes, muscle strength, and impaired physical function: the tip of the iceberg? Diabetes Care. 2005;28:2541–2542. doi: 10.2337/diacare.28.10.2541.
    1. Singh S, Bailey KR, Noheria A, Kullo IJ. Frailty across the spectrum of ankle-brachial index. Angiology. 2012;63:229–236. doi: 10.1177/0003319711413457.
    1. Steffick DE, The HRS working group (2000) Documentation of affective functioning measures in the Health and Retirement Study. HRS/AHEAD Documentation Report DR-005 [online report].
    1. Stenholm S, Strandberg TE, Pitkala K, Sainio P, Heliovaara M, Koskinen S. Midlife obesity and risk of frailty in old age during a 22-year follow-up in men and women: the Mini-Finland Follow-up Survey. J Gerontol A Biol Sci Med Sci. 2014;69:73–78. doi: 10.1093/gerona/glt052.
    1. Steptoe A, Breeze E, Banks J, Nazroo J. Cohort profile: the English Longitudinal Study of Ageing. Int J Epidemiol. 2013;42:1640–1648. doi: 10.1093/ije/dys168.
    1. Strandberg TE, Sirola J, Pitkala KH, Tilvis RS, Strandberg AY, Stenholm S. Association of midlife obesity and cardiovascular risk with old age frailty: a 26-year follow-up of initially healthy men. Int J Obes (Lond) 2012;36:1153–1157. doi: 10.1038/ijo.2012.83.
    1. The International Expert Committee International Expert Committee Report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1–8. doi: 10.2337/dc09-9033.
    1. von Haehling S, Anker SD, Doehner W, Morley JE, Vellas B. Frailty and heart disease. Int J Cardiol. 2013;168:1745–1747. doi: 10.1016/j.ijcard.2013.07.068.
    1. Walston J, Hadley EC, Ferrucci L, Guralnik JM, Newman AB, Studenski SA, Ershler WB, Harris T, Fried LP. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc. 2006;54:991–1001. doi: 10.1111/j.1532-5415.2006.00745.x.
    1. Wong CH, Weiss D, Sourial N, Karunananthan S, Quail JM, Wolfson C, Bergman H. Frailty and its association with disability and comorbidity in a community-dwelling sample of seniors in Montreal: a cross-sectional study. Aging Clin Exp Res. 2010;22:54–62. doi: 10.1007/BF03324816.

Source: PubMed

3
S'abonner